6XHL

Covalent complex of SARS-CoV main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide

Changes made to a PDB entry after its initial release are considered to be either “major” or “minor”. The latest minor version of each major version is available as a file download. More information about the PDB versioning is available.

Version Number	Version Date	Version Type/Reason	Version Change	Revised CIF Category
1.0	2020-07-08	Initial release
1.1	2020-11-04		Database references, Refinement description	citation, citation_author, software
1.2	2020-11-25		Database references	citation, citation_author	Download
2.0	2022-08-03		Database references, Derived calculations, Non-polymer description, Structure summary	chem_comp, database_2, entity, pdbx_entity_nonpoly, struct_conn
2.1	2023-10-18		Data collection, Refinement description	chem_comp_atom, chem_comp_bond, pdbx_initial_refinement_model
2.2	2024-11-06		Structure summary	pdbx_entry_details, pdbx_modification_feature	Download

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.